Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2021-004737-37Phase 4Active
Phase 4 trial of methylprednisolone in muscle weakness and functional disability, sponsored by Ziekenhuis Oost-Limburg. Primary endpoint: Postoperative muscle strength. Started Oct 2021; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2021-004737-37.